Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein

Spyros Zissimopoulos1, Naadiya Docrat, F Anthony Lai

  • 1Wales Heart Research Institute, Department of Cardiology, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom. zissimopouloss@cardiff.ac.uk

Insights

Oxidizing agents like H2O2 and diamide reduce the binding of FKBP to the ryanodine receptor (RyR) calcium channel. This redox regulation of RyR-FKBP interaction is crucial for cardiac function.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Physiology

Background:

  • The ryanodine receptor (RyR) calcium channel is a critical regulator of cellular calcium signaling.
  • FK506-binding protein (FKBP) modulates RyR channel activity, and its dissociation from RyR2 is linked to cardiac disease.
  • RyR channels are known to function as redox sensors.

Purpose of the Study:

  • To investigate the redox regulation of the association between the ryanodine receptor (RyR) and FKBP.
  • To determine if oxidizing agents affect the binding affinity between RyR2 and FKBP12.6.

Main Methods:

  • Co-immunoprecipitation assays using solubilized native RyR2 from cardiac muscle sarcoplasmic reticulum (SR) and recombinant [(35)S]FKBP12.6.
  • Co-sedimentation experiments with cardiac and skeletal muscle SR vesicles and [(35)S]FKBP12.6.
  • Utilized sulfhydryl-oxidizing agents like H(2)O(2) and diamide to assess redox effects.

Main Results:

  • Oxidizing agents H(2)O(2) and diamide significantly diminished RyR2-FKBP12.6 binding.
  • H(2)O(2) reduced binding to ~75% and diamide to ~50% of control levels.
  • The redox effect on FKBP binding is primarily mediated through sites on the ryanodine receptor, not FKBP.

Conclusions:

  • The redox state of the ryanodine receptor directly influences its binding affinity for FKBP.
  • Understanding this redox regulation is vital for comprehending RyR channel function and its role in cardiac health and disease.
  • The drug K201 did not restore FKBP binding under oxidizing conditions, suggesting complex regulatory mechanisms.

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...